Drug Evaluation, Preclinical.

Drug-like properties = concepts, structure design and methods : from ADME to toxicity optimization / by: (書目-語言資料,印刷品)

Evaluation of drug candidates for preclinical development = pharmacokinetics, metabolism, pharmaceutics, and toxicology / by: (書目-語言資料,印刷品)

Drug safety evaluation by: (書目-語言資料,印刷品)

Anticancer drug development by: (書目-語言資料,印刷品)

Histopathology of preclinical toxicity studies = interpretation and relevance in drug safety evaluation / by: (書目-語言資料,印刷品)

Controversial statistical issues in clinical trials by: (書目-語言資料,印刷品)

Safety pharmacology in pharmaceutical development = approval and post marketing surveillance / by: (書目-語言資料,印刷品)

Translational ADMET for drug therapy = principles, methods, and pharmaceutical applications / by: (書目-語言資料,印刷品)

Oral bioavailability assessment = basics and strategies for drug discovery and development / by: (書目-語言資料,印刷品)

Toxicity Tests.

Laboratory animals

Pharmaceutical chemistry.

Administration, Oral.

Cancer

Anticancereux

Drug Industry

Pharmacokinetics.

Pathology.

MEDICAL

Drug development

Animals, Laboratory.

Drug development.

Clinical Trials as Topic.

Drugs

Drug Toxicity.

Drug Approval.

HEALTH & FITNESS

Histology.

Pharmaceutical Preparations

Drug Design.

Structure-Activity Relationship.

Clinical trials.

Drug Evaluation.

Toxicokinetics.

Antineoplastic Agents.

Drug Evaluation, Preclinical.

Drug Discovery.

Dental pharmacology.

Drug-Related Side Effects and Adverse Reactions.

Pharmacology

Product Surveillance, Postmarketing.

Data Interpretation, Statistical.

Biological Availability.

Antineoplastic agents.